Last edition
News about "Sai Life Sciences"
Sai Life Sciences Completes Phase-II of Production Block 11 at Bidar site
Sai Life Sciences’ Unit IV in Bidar is the company’s flagship manufacturing site, specialising in the production of APIs and advanced intermediates for markets such as the US, EU and Japan.
Sai Life Sciences | 29/08/2025 | By Dineshwori
Sai Life Sciences Establishes Peptide Research Centre in Hyderabad
Sai Life Sciences has inaugurated a state-of-the-art Peptide Research Centre at its Hyderabad R&D campus, expanding its capabilities in complex peptide synthesis and conjugation to support next-generation therapeutics.
Sai Life Sciences | 04/04/2025 | By Abha | 166
Sai Life Sciences Eyes Global Expansion as Revenue Hits INR 1,115.1 Crore
The company reported a 15 percent increase in revenue and a 36 percent rise in net profit compared to the same period last year, driven by strong execution, expanding capacity, and deepening customer relationships.
Sai Life Sciences | 10/02/2025 | By Aishwarya | 495
Sai Life Sciences unveils opens research facility for Schrodinger in Hyderabad
In January 2023, Sai Life Sciences entered into a five-year strategic agreement with Schrodinger
Sai Life Sciences | 21/04/2023 | By Sudeep Soparkar | 658
Sai Life Sciences unveils GMP Kilo Lab in Alderley Park, Manchester, UK
The new GMP Kilo Lab will enable Sai Life Sciences to offer drug substances and intermediates supplies ranging from gram to kilogram quantities
Sai Life Sciences | 16/03/2023 | By Sudeep Soparkar | 543
Sai Life Sciences opens high-potency API manufacturing facility at Bidar Campus
The facility is spread across 16000 sq ft HPAPI block
Sai Life Sciences | 17/01/2023 | By Sudeep Soparkar | 1007
The lab will be a dedicated facility for integrated discovery work streams including medicinal and synthetic chemistry, in vitro biology, and process chemistry
Sai Life Sciences | 11/01/2023 | By Sudeep Soparkar | 1108
Stephen Hermitage joins Sai Life Sciences as VP, CMC
He will add further deep scientific, process development and drug development experience to the R&D organisation
<br />
Sai Life Sciences | 23/11/2022 | By Sudeep Soparkar | 294
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy